Answer the following questions descriptively. Each question carries 5 points 1. Describe two stakeholder issues that the introduction of Point-of-Care medical testing creates (who are the stakeholders and what are the issues?) 2. Why aren't competitors typically considered stakeholders in the biodesign innovation process